Organic Chemistry Methods TRIZ Cases

Tetramethyl diethynylazobenzene resolves stability-control trade-offs in optical storage by stabilizing cis-isomers through ortho-methyl substitution.

Heterocyclic ligand frameworks coordinate metal centers to boost photoluminescence quantum yield, resolving color saturation trade-offs in flexible displays.

Sulfonic acid compounds suppress by-product formation during aliphatic polyester depolymerization, resolving purity and efficiency trade-offs.

Compounds activate store-operated calcium entry pathways to reduce viral replication without cytotoxicity.

Triphenylene derivatives with electron-deficient heteroaryl groups extend OLED lifetimes and reduce operating voltages by optimizing charge transport.

Formula I compounds modulate RXFP1 receptors, reducing blood pressure drops while sustaining therapeutic effects.

Heating a reaction mixture with 1,2-propanediol resolves yield and time trade-offs in purine synthesis.

Sulfonium borate complex reduces fluorine ion production to prevent electrochemical corrosion while achieving rapid low-temperature curing.

Converts the acid into a lactone derivative for selective crystallization, removing isomers without expensive catalysts.

Halogenated aromatic blocks enhance phase separation and etching selectivity, resolving insufficient vertical orientation on untreated substrates.

A platinum-based organometallic compound manages charge carrier balance to improve color purity and emission efficiency without increasing driving voltage.

A quinone methide and diimide combination inhibits vinyl monomer polymerization through synergistic chemical action.

A host-dopant composition boosts luminous efficiency while resolving color purity and lifespan trade-offs.

A compound featuring a dibenzofuran group bonded via a phenylene linker to a central nitrogen atom improves charge carrier injection in organic electroluminescent devices.

Carboplatin co-crystals improve solubility and stability via hydrogen bonding, reducing toxicity while expanding therapeutic versatility.

Controlled freeze drying at -170 to -180 C produces reproducible amorphous raltegravir potassium with improved stability.

Early chiral resolution in Zanubrutinib synthesis eliminates late-stage HPLC, boosting yield and purity.

Developing a crystalline pomalidomide hemihydrate resolves stability versus dissolution trade-offs.

Inert gas displacement rapidly cools a propane ammoxidation reactor, preventing catalyst degradation during safe reaction stopping.

Ligand LA complexes with transition metals produce saturated red, green, and blue emissions without absorption filters.

Modifying the pyrene core structure optimizes energy band gaps to resolve efficiency and stability trade-offs.

Supramolecular self-assembly creates a carbon nitride photocatalyst that resolves electron-hole recombination while maintaining structural stability.

Controlled water partial pressure suppresses oligomerization on a copper-iron catalyst, maintaining high alcohol conversion rates.

5-Azaindazole derivatives block A2A and A2B receptors to prevent immunosuppression and support anti-tumor T cell activity.

A sulfoxide-based reagent with permanently charged units enables sensitive peptide detection via mass spectrometry.

A Cu-catalyzed asymmetric hydroboration process converts chromenes into chiral flavan-3-ols with high enantiomeric excess.

Crystallization replaces chromatography to purify Eluxadoline intermediate, boosting yield and scalability.

NBD-Cl modification of amino acid derivatives resolves the contradiction between inhibitor effectiveness and biological activity traceability.

Direct phosgenation of sorbic acid salts prevents rapid isomerization, achieving high purity and yield without ammonium chloride waste.

Tetradentate organometallic compounds emit saturated colors directly, resolving the trade-off between color accuracy and manufacturing cost.

SV2A-binding radioligands provide non-invasive synaptic density assessment, replacing indirect glucose metabolism methods to improve diagnostic accuracy.

A specific organic compound structure prevents intermolecular stacking to enhance hole mobility and luminescence efficiency.

Dasatinib co-crystals and solvate forms provide enhanced therapeutic efficacy and stability, addressing limited treatment options for leukemia.

Crystalline forms S1 and S2 of lifitegrast enable high-yield production through controlled precipitation and suspension processes.

Strategic inert zoning in fixed-bed reactors mitigates hot spots to stabilize ammoxidation reactions and enhance aromatic nitrile yield.

Norbornenyl unnatural amino acids enable site-specific protein labeling via copper-free click chemistry.

Silica-supported multi-metal oxide catalyst reduces byproduct formation and ammonia consumption while maintaining high acrylonitrile yield.

Switching the crystallisation solvent from ethanol to methanol resolves legislative tax burdens while maintaining high purity of the sun protection tautomer.

A fused polycyclic compound in the emission layer suppresses Dexter energy transfer to enhance luminous efficiency.

Toluene solvate crystallization isolates intermediate III, eliminating hazardous diisopropyl ether use and improving process safety.

One-pot sulfonation of 4-(2-pyridyldithio)butanoic acid eliminates multi-step synthesis bottlenecks, improving aqueous solubility and therapeutic efficacy.

Mandelate salts resolve needle morphology and corrosivity issues in atrasentan monohydrochloride manufacturing.

Imidazolopyrazine compounds inhibit PERK kinase activity to disrupt the unfolded protein response pathway, overcoming tumor cell survival under stress.

Monoclonal antibodies detect pre-Haptoglobin-2 without cross-reacting with Haptoglobin-1 or Haptoglobin-2.

Aromatic hydrocarbon solvents enable high-concentration slurry reactions for 2-aminonicotinic acid benzyl ester derivatives using phase transfer catalysts.